Melatonite

Melatonin, the active ingredient in Melatonite, is a sleep‑disorder agent presented as an unspecified strength/tablet for oral use. It helps regulate the circadian rhythm and is used to manage insomnia and jet lag in adults.

GNH USA supplies Melatonite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonite (melatonin) acts on the melatonin receptor pathway to support sleep regulation.

Insomnia: improves sleep onset and maintenance in adults. Jet lag: assists in realigning the internal clock after rapid time‑zone travel. Delayed sleep phase syndrome: helps advance sleep timing to a more conventional schedule.

Melatonite is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: occasional lingering drowsiness. - Nausea: mild gastrointestinal upset. - Vivid dreams: unusual or intense dreaming. - Mild stomach discomfort: occasional abdominal irritation.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or irritability. - Severe dizziness: prolonged vertigo or loss of balance. - Hallucinations: visual or auditory disturbances. - Seizures: rare occurrence in predisposed individuals. - Severe depression: worsening of depressive symptoms.

When considering Melatonite, several safety measures are recommended.

Assess renal function: evaluate kidney status before initiating therapy. Consult healthcare provider: discuss use in children, adolescents, or the elderly. Avoid operating machinery: potential drowsiness may impair performance. Do not combine with alcohol: may enhance sedative effects. Pregnancy safety: benefits and risks should be weighed with a physician. Store at ambient temperature: keep in the original pack, protect from moisture and light.

Melatonite may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Fluoxetine (CYP1A2 inhibitor): may increase melatonin plasma levels. - Warfarin (anticoagulant): potential enhancement of anticoagulant effect. - Cyclosporine (immunosuppressant): possible reduction in immunosuppressive efficacy.

Moderate Interactions (Monitor Closely): - Benzodiazepines (sedative): additive drowsiness. - Oral contraceptives: may lower melatonin effectiveness. - SSRIs (antidepressants): possible alteration of sleep architecture.